Science FDA clears first IV biologic to cross blood-brain barrier, upending CNS trial playbook Nathan Cole · July 19, 2026
Science New preclinical drug candidate shows promise reducing levodopa side effects ahead of 2027 human trials Nathan Cole · July 15, 2026
Science
